Ex-vivo Performance Evaluation of the Histolog™ Scanner for Human Breast Carcinoma Detection on Fresh Breast Core Biopsies

Fresh breast core biopsies suspicious for breast cancer that are usually taken during clinical breast assessments will be imaged via confocal microscopy. The device so called HistologTM Scanner is based on confocal fluorescence and displays microscopic histology images superficial layers of fresh tissue. After the imaging procedure the fresh breast tissue specimen will be followed according to the gold standard workflow (H\&E-stained images). Subsequently, two pathologists will analyze the HistologTM Scanner obtained-images and H\&E-stained images for potential breast cancer structures. A comparison of both analyses for cancer visualization will be performed to evaluate the feasibility of using confocal microscopy for breast cancer detection.

Sex

Female

Minimum age

18 Years

Inclusion Criteria:

* Adult female patient ≥18 years old.
* Patient presenting with suspected breast carcinoma.
* Patient eligible for biopsy sampling.
* Patient must sign a written informed consent prior to research project entry.

Exclusion Criteria:

* Patient previously treated for breast carcinoma.
* Patient has undergone previous neo-adjuvant treatment.
* Patient is not willing to participate in the research project.
* Patient is not capable of consenting.
* Patient is younger than 18 years old
* Patient is male